Cresset Asset Management, LLC Biogen Inc. Transaction History

Cresset Asset Management, LLC

$23.6 Billion
Q2 2024

A detailed history of Cresset Asset Management, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Cresset Asset Management, LLC holds 10,148 shares of BIIB stock, worth $1.76 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

10,148

Previous 9,198 10.33%

Holding current value

$1.76 Million

Previous $1.98 Million 18.61%

% of portfolio

0.01%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$190.52 - $236.72 $180,994 - $224,884	950 Added 10.33%	10,148 $2.35 Million
Q1 2024 May 15, 2024	SELL	$212.02 - $267.71 $247,639 - $312,685	-1,168 Reduced 11.27%	9,198 $1.98 Million
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $956,691 - $1.15 Million	4,298 Added 70.83%	10,366 $2.68 Million
Q3 2023 Nov 14, 2023	SELL	$253.3 - $285.89 $173,003 - $195,262	-683 Reduced 10.12%	6,068 $1.56 Million
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $1.49 Million - $1.72 Million	5,401 Added 400.07%	6,751 $1.92 Million
Q1 2023 May 12, 2023	SELL	$256.56 - $292.34 $315,825 - $359,870	-1,231 Reduced 47.69%	1,350 $375,000
Q4 2022 Feb 14, 2023	SELL	$252.44 - $306.72 $80,275 - $97,536	-318 Reduced 10.97%	2,581 $714,000
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $12,460 - $17,181	-64 Reduced 2.16%	2,899 $775,000
Q2 2022 Aug 15, 2022	SELL	$187.54 - $223.02 $113,836 - $135,373	-607 Reduced 17.0%	2,963 $602,000
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $156,566 - $197,265	-808 Reduced 18.46%	3,570 $752,000
Q4 2021 Feb 10, 2022	SELL	$223.92 - $287.77 $75,908 - $97,554	-339 Reduced 7.19%	4,378 $1.05 Million
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $372,414 - $485,669	1,316 Added 38.69%	4,717 $1.34 Million
Q2 2021 Aug 10, 2021	SELL	$259.0 - $414.71 $99,197 - $158,833	-383 Reduced 10.12%	3,401 $1.18 Million
Q1 2021 May 12, 2021	BUY	$242.95 - $284.63 $94,750 - $111,005	390 Added 11.49%	3,784 $1.06 Million
Q4 2020 Feb 11, 2021	SELL	$236.26 - $355.63 $218,776 - $329,313	-926 Reduced 21.44%	3,394 $831,000
Q3 2020 Nov 13, 2020	BUY	$264.77 - $305.71 $101,936 - $117,698	385 Added 9.78%	4,320 $1.23 Million
Q2 2020 Aug 04, 2020	BUY	$258.66 - $342.55 $449,809 - $595,694	1,739 Added 79.19%	3,935 $1.05 Million
Q1 2020 May 15, 2020	BUY	$268.85 - $341.04 $197,873 - $251,005	736 Added 50.41%	2,196 $695,000
Q4 2019 Feb 10, 2020	BUY	$220.06 - $304.07 $35,649 - $49,259	162 Added 12.48%	1,460 $433,000
Q3 2019 Nov 13, 2019	BUY	$217.44 - $243.88 $282,237 - $316,556	1,298 New	1,298 $302,000
Q2 2019 Aug 12, 2019	SELL	$219.29 - $241.72 $213,588 - $235,435	-974 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $88,634 - $138,634	409 Added 72.39%	974 $230,000
Q4 2018 May 21, 2019	BUY	$278.5 - $352.75 $157,352 - $199,303	565 New	565 $170,000

Others Institutions Holding BIIB

# of Institutions

1,016

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cresset Asset Management, LLC with notifications on news.

Account

Cresset Asset Management, LLC Biogen Inc. Transaction History